Establishing the efficacy of Gliadel wafers: progress towards a Phase III trial
Acta Neurochir (Wien)
.
2013 Jan;155(1):61-2.
doi: 10.1007/s00701-012-1533-8.
Epub 2012 Oct 30.
Authors
Colin Watts
,
Laurence Dunn
,
Keyoumars Ashkan
,
Michael Jenkinson
,
Paul Smith
PMID:
23108559
DOI:
10.1007/s00701-012-1533-8
No abstract available
Publication types
Letter
Comment
MeSH terms
Brain Neoplasms / therapy*
Carmustine / adverse effects*
Glioblastoma / therapy*
Humans
Male
Neoplasm Recurrence, Local / therapy*
Substances
Carmustine
Grants and funding
G108/507/MRC_/Medical Research Council/United Kingdom